Exhibit 10.14
Infinity
Pharmaceuticals
Effective as of March 31,
2006
Adelene Q. Perkins
83 Lincoln Road
Wayland, MA 01778
Dear Adelene:
Reference is hereby made to that
certain Restricted Stock Agreement (the “Stock Restriction
Agreement”) dated March 19, 2002 between Infinity
Pharmaceuticals, Inc. (the “Company”) and you, pursuant
to which the Company issued and sold to you an aggregate of 450,000
shares (the “Shares”) of common stock, $.0001 par value
per share (the “Common Stock”), of the Company. As of
April 1, 2006, all 450,000 Shares (the “Vested
Shares”) had vested and were no longer subject to the
Purchase Option (as defined in the Stock Restriction
Agreement).
The aggregate purchase price for the
Shares was paid by you by delivery of that certain Secured
Promissory Note and Pledge Agreement dated as of March 19,
2002 in the principal amount of $67,500 (the “Promissory
Note”), except that the aggregate par value of the Shares was
paid by you by check. As of March 31, 2006, you owe the
Company an aggregate of $81,153.91, representing the entire
princi
